Literature DB >> 19177532

Mutations in MFSD8/CLN7 are a frequent cause of variant-late infantile neuronal ceroid lipofuscinosis.

Chiara Aiello1, Alessandra Terracciano, Alessandro Simonati, Giancarlo Discepoli, Natalia Cannelli, Dianela Claps, Yanick J Crow, Marzia Bianchi, Claudia Kitzmuller, Daniela Longo, Antonietta Tavoni, Emilio Franzoni, Alessandra Tessa, Edwige Veneselli, Renata Boldrini, Mirella Filocamo, Ruth E Williams, Enrico S Bertini, Roberta Biancheri, Rosalba Carrozzo, Sara E Mole, Filippo M Santorelli.   

Abstract

The neuronal ceroid lipofuscinoses (NCL) are a group of genetically heterogeneous neurodegenerative disorders. The recent identification of the MFSD8/CLN7 gene in a variant-late infantile form of NCL (v-LINCL) in affected children from Turkey prompted us to examine the relative frequency of variants in this gene in Italian patients with v-LINCL. We identified nine children harboring 11 different mutations in MFSD8/CLN7. Ten mutations were novel and included three nonsense (p.Arg35Stop, p.Glu381Stop, p.Arg482Stop), four missense (p.Met1Thr, p.Gly52Arg, p.Thr294Lys, p.Pro447Leu), two splice site mutations (c.863+3_4insT, c.863+1G>C), and a 17-bp deletion predicting a frameshift and premature protein truncation (c.627_643del17/p.Met209IlefsX3). The clinical phenotype, which was similar to that of the Turkish v-LINCL cases, was not influenced by type and location of the mutation nor the length of the predicted residual gene product. As well as identifying novel variants in MFSD8/CLN7, this study contributes to a better molecular characterization of Italian NCL cases, and will facilitate medical genetic counseling in such families. The existence of a subset of v-LINCL cases without mutations in any of the known NCL genes suggests further genetic heterogeneity. 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19177532     DOI: 10.1002/humu.20975

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  23 in total

Review 1.  Therapeutic approaches to the challenge of neuronal ceroid lipofuscinoses.

Authors:  R Kohan; I A Cismondi; A M Oller-Ramirez; N Guelbert; Tapia V Anzolini; G Alonso; S E Mole; Dodelson R de Kremer; Noher I de Halac
Journal:  Curr Pharm Biotechnol       Date:  2011-06       Impact factor: 2.837

2.  Expression and lysosomal targeting of CLN7, a major facilitator superfamily transporter associated with variant late-infantile neuronal ceroid lipofuscinosis.

Authors:  A Sharifi; M Kousi; C Sagné; G C Bellenchi; L Morel; M Darmon; H Hulková; R Ruivo; C Debacker; S El Mestikawy; M Elleder; A-E Lehesjoki; A Jalanko; B Gasnier; A Kyttälä
Journal:  Hum Mol Genet       Date:  2010-09-07       Impact factor: 6.150

3.  Mfsd8 Modulates Growth and the Early Stages of Multicellular Development in Dictyostelium discoideum.

Authors:  Shyong Quan Yap; William D Kim; Robert J Huber
Journal:  Front Cell Dev Biol       Date:  2022-06-09

4.  Novel in-frame deletion in MFSD8 gene revealed by trio whole exome sequencing in an Iranian affected with neuronal ceroid lipofuscinosis type 7: a case report.

Authors:  Ali Hosseini Bereshneh; Masoud Garshasbi
Journal:  J Med Case Rep       Date:  2018-09-25

5.  Rare variants in the neuronal ceroid lipofuscinosis gene MFSD8 are candidate risk factors for frontotemporal dementia.

Authors:  Ethan G Geier; Mathieu Bourdenx; Nadia J Storm; J Nicholas Cochran; Daniel W Sirkis; Ji-Hye Hwang; Luke W Bonham; Eliana Marisa Ramos; Antonio Diaz; Victoria Van Berlo; Deepika Dokuru; Alissa L Nana; Anna Karydas; Maureen E Balestra; Yadong Huang; Silvia P Russo; Salvatore Spina; Lea T Grinberg; William W Seeley; Richard M Myers; Bruce L Miller; Giovanni Coppola; Suzee E Lee; Ana Maria Cuervo; Jennifer S Yokoyama
Journal:  Acta Neuropathol       Date:  2018-10-31       Impact factor: 17.088

Review 6.  Interactions of the proteins of neuronal ceroid lipofuscinosis: clues to function.

Authors:  Amanda L Getty; David A Pearce
Journal:  Cell Mol Life Sci       Date:  2010-08-01       Impact factor: 9.207

Review 7.  Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Jessica Root; Paola Merino; Austin Nuckols; Michelle Johnson; Thomas Kukar
Journal:  Neurobiol Dis       Date:  2021-03-31       Impact factor: 7.046

8.  A rare homozygous MFSD8 single-base-pair deletion and frameshift in the whole genome sequence of a Chinese Crested dog with neuronal ceroid lipofuscinosis.

Authors:  Juyuan Guo; Dennis P O'Brien; Tendai Mhlanga-Mutangadura; Natasha J Olby; Jeremy F Taylor; Robert D Schnabel; Martin L Katz; Gary S Johnson
Journal:  BMC Vet Res       Date:  2015-01-03       Impact factor: 2.741

9.  Loss of CLN7 results in depletion of soluble lysosomal proteins and impaired mTOR reactivation.

Authors:  Tatyana Danyukova; Khandsuren Ariunbat; Melanie Thelen; Nahal Brocke-Ahmadinejad; Sara E Mole; Stephan Storch
Journal:  Hum Mol Genet       Date:  2018-05-15       Impact factor: 6.150

10.  Molecular epidemiology of childhood neuronal ceroid-lipofuscinosis in Italy.

Authors:  Filippo Maria Santorelli; Barbara Garavaglia; Francesco Cardona; Nardo Nardocci; Bernardo Dalla Bernardina; Stefano Sartori; Agnese Suppiej; Enrico Bertini; Dianela Claps; Roberta Battini; Roberta Biancheri; Mirella Filocamo; Francesco Pezzini; Alessandro Simonati
Journal:  Orphanet J Rare Dis       Date:  2013-02-02       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.